You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tp53

Showing 26 - 50 of 1,062
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Portland (Decitabine and

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Decitabine and Cedazuridine
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
May 25, 2022

p53 and Response to Preoperative Radiotherapy for T2 and T3

Recruiting
  • Rectal Cancer
  • preoperative short course radiation
  • Vienna, Austria
    Medical University of Vienna, Department of Surgery
Apr 6, 2022

Prevention of Chemo-induced Myelosuppression Trial in Worldwide (ALRN-6924, TAC (doxorubicin 50 mg/m2; cyclophosphamide 500

Recruiting
  • Prevention of Chemotherapy-induced Myelosuppression
  • ALRN-6924
  • TAC (doxorubicin 50 mg/m2; cyclophosphamide 500 mg/m2; docetaxel 75 mg/m2)
  • Tamarac, Florida
  • +14 more
Jan 31, 2023

Myeloid Malignancy Trial in United States (APR-246, Venetoclax, Azacitidine)

Completed
  • Myeloid Malignancy
  • New Haven, Connecticut
  • +7 more
Jan 18, 2022

Patogenic Mutation in 5 Genes

Completed
  • Colorectal Cancer
  • +5 more
  • co-occuring mutation
  • Jakarta, ALL, Indonesia
    Vania Myralda Giamour Marbun
Jul 21, 2021

Acute Myeloid Leukemia or MDS Trial in United States (APR-246)

Completed
  • Acute Myeloid Leukemia or Myelodysplastic Syndromes
  • Tampa, Florida
  • +6 more
Jan 18, 2022

Pancreatic Tumors, Solid Tumors, Biliary Tract Cancer Trial (BI 907828)

Not yet recruiting
  • Pancreatic Neoplasms
  • +2 more
  • BI 907828
  • (no location specified)
Aug 22, 2022

Solid Tumor Trial in United States (ASTX295)

Recruiting
  • Solid Tumor
  • Duarte, California
  • +9 more
Nov 18, 2022

Myelodysplastic Syndrome, Acute Myeloid Leukemia, Myeloproliferative Tumor Trial in United States (APR-246, Azacitidine)

Completed
Has Results
  • Myelodysplastic Syndrome
  • +3 more
  • Tampa, Florida
  • +5 more
Jan 14, 2022

Leukemia, Lymphocytic, Chronic Trial in Germany (ibrutinib, obinutuzumab, venetoclax)

Completed
  • Leukemia, Lymphocytic, Chronic
  • Dresden, Germany
  • +10 more
Jan 13, 2023

Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)

Not yet recruiting
  • Hematologic Malignancy
  • +21 more
  • (no location specified)
Feb 9, 2023

Ovarian Endometrioid Tumor, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Toronto (Atezolizumab, Bevacizumab)

Recruiting
  • Ovarian Endometrioid Tumor
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Oct 21, 2021

Colorectal Cancer Metastatic, Colorectal Cancer Stage IV, TP53 Gene Mutation Trial in Bergen (Cyclophosphamide)

Terminated
  • Colorectal Cancer Metastatic
  • +2 more
  • Bergen, Norway
    Haukeland University Hospital
Jan 20, 2021

Adult Solid Tumor, Bladder Carcinoma, Colon Carcinoma Trial in Duarte (Laboratory Biomarker Analysis, Modified Vaccinia Virus

Active, not recruiting
  • Adult Solid Neoplasm
  • +16 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

Advanced Solid and Hematological TP53wt Tumors Trial in Worldwide (HDM201, ancillary treatment)

Completed
  • Advanced Solid and Hematological TP53wt Tumors
  • Boston, Massachusetts
  • +14 more
May 20, 2021

Exploiting Pathogenic Tp53 Mutation for Early Diagnosis of

Not yet recruiting
  • Ovarian Cancer
  • Patients with Ovarian cancer and pap test available
  • Milan, Italy
  • +1 more
Mar 19, 2021

Chronic Lymphocytic Leukemia Trial (Zebutinib&BR or Zebutinib&FCR)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Zebutinib&BR or Zebutinib&FCR
  • (no location specified)
Jul 27, 2021

Lung Cancer Trial in United States (Osimertinib, Platinum, Etoposide)

Recruiting
  • Lung Cancer
  • Basking Ridge, New Jersey
  • +6 more
Jul 1, 2022

Non-small Cell Carcinoma, EGFR Gene Mutation Trial in Guangzhou (Osimertinib 80 MG [Tagrisso], Pemetrexed 500 MG Injection,

Not yet recruiting
  • Non-small Cell Carcinoma
  • EGFR Gene Mutation
  • Osimertinib 80 MG [Tagrisso]
  • +2 more
  • Guangzhou, Guangdong, China
    Department of Medical Oncology,Cancer Center of Sun Yat-Sen Univ
Jan 3, 2021

Acute Myeloid Leukemia Trial in Worldwide (Magrolimab, Venetoclax, Azacitidine)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Magrolimab
  • +6 more
  • Duarte, California
  • +25 more
Feb 4, 2022

Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage

Active, not recruiting
  • Clinical Stage III Gastric Cancer AJCC v8
  • +7 more
  • Duarte, California
  • +30 more
Jan 7, 2023

Squamous Cell Carcinoma Trial in Singapore (Afatinib)

Not yet recruiting
  • Squamous Cell Carcinoma
  • Singapore, Singapore
    National University Hospital
Aug 26, 2020

Chronic Lymphocytic Leukemia (CLL) Trial in Worldwide (Obinutuzumab, Venetoclax, Fludarabine)

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Aurora, Colorado
  • +55 more
Jan 30, 2023

Chronic Lymphocytic Leukemia Trial in Germany (Obinutuzumab, Venetoclax, Acalabrutinib)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Bad Saarow, Germany
  • +29 more
May 4, 2022

The Role of Hypoxia as a Selective Pressure for TP53 Mutations

Terminated
  • Endometrial Cancer
    • Sutton, Surrey, United Kingdom
      The Institute of Cancer Research & The Royal Marsden NHS Foundat
    Jan 27, 2020